BioTech Mag Search: Syndication
RNAi trailblazer Alnylam teases more positive data for a potential third commercial drug
RNAi pioneer Alnylam snagged its first and second FDA approvals in the last two years. And on Wednesday, the Cambridge, MA-based biotech announced it has more positive data to...
3 hours ago - San Diego Biotechnology - 2 articles
Micronoma Appoints Magda Marquet Chairman of the Board
Biotech maven joins early-stage cancer detection company utilizing innovative microbiome analysis SAN DIEGO, Sept. 30, 2020 /PRNewswire/ - Micronoma, an early stage...
7 hours ago - San Diego Biotechnology
CRB's SlateXpace gives cell and gene therapy clients new flexibility, control over manufacturing needs to support highly complex product pipelines
CRB, a leader in the design and construction of biotech manufacturing facilities, creates SlateXpace - a multimodal facility solution that delivers unmatched industry speed...
7 hours ago - San Diego Biotechnology
Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
CAMBRIDGE, Mass.--Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today positive topline results from the ILLUMINATE-B pediatric Phase 3 study...
7 hours ago - San Diego Biotechnology - 2 articles
Pfizer infuses $200M into CStone, scoring a second PD-L1 and outlining a sprawling China pact
Pfizer has engineered a wide-ranging China pact with CStone, with an initial $200 million investment and a license to the late-stage PD-L1 drug to get things started. The US...
7 hours ago - San Diego Biotechnology - 2 articles
Associate Scientist, Cancer Biology & Translational Research - Turning Point Therapeutics - San Diego, CA
Analyze and document experimental data in notebooks in a timely and accurate manner per company policies. We are applying a highly refined design methodology...From Turning...
14 hours ago - San Diego Biotechnology - 3 articles
Cardiff Oncology Prices Public Offering
SAN DIEGO, Sept. 29, 2020 /PRNewswire/ - Cardiff Oncology, Inc. , a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical...
14 hours ago - San Diego Biotechnology
Research Technician - Scripps Research Institute - La Jolla, CA
We are currently one of the top-10 producers of virus genomic data in the world and we are aiming to scale massively in the coming months and years. $18 - $22 an hourFrom...
15 hours ago - San Diego Biotechnology - 3 articles
Research Associate, Immunoassay - Wondfo USA - San Diego, CA
Document results while keeping an organized and comprehensive experimental notebook. Work collaboratively to foster professional, constructive relationships as...From Wondfo...
15 hours ago - San Diego Biotechnology - 3 articles
Cell Biology Scientist III - Thermo Fisher Scientific - Carlsbad, CA
Genomic editing in several cell lines (TALEN and CRISPR based editing, design and implementation). Design and plan experiments independently.From Thermo Fisher Scientific...
15 hours ago - San Diego Biotechnology - 2 articles
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
An Innovative Pattern: Scientists Rewrite Rules for 2D Electronics
Near-field scanning microscope image of nanocircuits “written” into a 2D device made of boron nitride and graphene. A research team led by Alex Zettl , senior faculty...
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug
Ovid Therapeutics and Takeda Pharmaceutical joined forces three years ago to develop a small molecule into a potential epilepsy drug. That research is starting to pay off as...
Synthetic Pathways Turn Plants into Biofactories for New Molecules
Plants can produce a wide range of molecules, many of which help them fight off harmful pests and pathogens. Biologists have harnessed this ability to produce many molecules...
Transforming Waste into Bio-Based Chemicals
Researchers at Berkeley Lab have transformed lignin, a waste product of the paper industry, into a precursor for a useful chemical with a wide range of potential...
Providing New Technologies for Vaccine Development
Credit: Design Cells/Shutterstock Vaccines, which help the body recognize infectious microorganisms and stage a stronger and faster response, are made up of proteins that are...
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China
CStone Pharmaceuticals has touted its experimental drug sugemalimab as potentially the best in its class of cancer immunotherapies. Pfizer is placing a bet on that promise by...
New Research Provides Clues on Optimizing Cell Defenses When Viruses Attack
UC San Diego scientists are providing new clues on how cells defend themselves from attack from viruses. The new study advance's science's understanding of interferons...
Kawasaki Disease is not a Homogenous Disease nor are its Triggers
Researchers at UC San Diego report that while Kawasaki disease occurs in clusters, the traits, and thus the triggers of the inflammatory disease vary among clusters. ...
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins
Orphazyme has fresh cash from the sale of shares in the US and Europe, which will support its lead rare disease drug through regulatory review and, if approved, a launch. But...
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
Praxis Precision Medicines kept mostly quiet about its research on central nervous system disorder drugs until May, when it emerged from stealth and revealed $100 million in...